Advertisement

Opioids II pp 361-392 | Cite as

Opioids in Immunologic Processes

  • H. U. Bryant
  • J. W. Holaday
Part of the Handbook of Experimental Pharmacology book series (HEP, volume 104 / 2)

Abstract

The immune response consists of a number of concerted events including recognition processing of foreign antigen proliferation differentiation of responder cells the production of peptide and protein mediators for amplification and regulation of the response. It is clear that the immune system is not isolated autonomous; rather it constitutes one-third of a triad of communicative networks (including the nervous system endocrine system) which are intimately interactive. A wealth of information is now available demonstrating the control the brain exercises over the immune system. The ability of stressful situations to produce dramatic alterations in immune status is indicative of this control exerted by the brain via neuronal pathways or modulation of endocrine outflow. The immune system can also affect brain function, as demonstrated by elevations in brain neurotransmitter levels (Barneound et al. 1988) and enhanced electrical activity in certain brain nuclei (Saphier et al. 1987) following activation of the immune system subsequent to bacterial infection. Within this neuroendocrine-immune axis feedback loops have been identified with immune cell products (e.g. interleukin-1) capable of stimulating the hypothalamo-pituitary-adrenal axis (BERNTON et al. 1987) leading to the production of glucocorticoids which are well-known immunomodulators.

Keywords

Mast Cell Natural Killer Cell Opioid Receptor Chronic Fatigue Syndrome Acquire Immune Deficiency Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Arora PK, Fride E, Petitto J, Waggie K, Skolnick P (1990) Morphine induced immune alterations in vivo. Cell Immunol 126:343–353PubMedGoogle Scholar
  2. Astrauskas V, Leonaviciene L (1987) Influence of injections of beta-endorphin in different doses into the lateral ventricle of brain on the development of adjuvant arthritis in rats. Ann NY Acad Sci 496:170–172Google Scholar
  3. Ausiello CM, Roda LG (1984) Leu-enkephalin binding to cultured human Tlymphocytes. Cell Bioi Int Rep 8:353–362Google Scholar
  4. Ayelsworth CF, Hodson CA, Meites J (1979) Opiate antagonists can inhibit mammary tumor growth in rats. Proc Soc Exp Bioi Med 161:18–20Google Scholar
  5. Barneound P, Rivet JM, Vitello S, Le Moal M, Nevea PJ (1988) Brain norepinephrine levels after BCG stimulation of the immune system. Immunol Lett 18:201–204PubMedGoogle Scholar
  6. Bayer BM, Daussin S, Hernandez M, Irvin L (1990) Morphine inhibition of lymphocyte activity is mediated by an opioid dependent mechanism. Neuropharmacology 29:369–374PubMedGoogle Scholar
  7. Beilin B, Martin FC, Shavit Y, Gale RP, Liebeskind JC (1989) Suppression of natural killer cell activity by high dose narcotic anesthesia in rats. Brain Behav Immunol 3:129–137Google Scholar
  8. Benyon RC, Lowman MA, Church MK (1987) Human skin mast cells:their dispersion, purification and secretory characterization. J Immunol 138:861–867PubMedGoogle Scholar
  9. Benyon RC, Robinson C, Church MK (1989) Differential release of histamine and eicosanoids from human skin mast cells activated by IgE-dependent and nonimmunologic stimuli. Br J Pharmacol 97:898–904PubMedGoogle Scholar
  10. Bernton EW, Beach JE, Holaday JW, Smallridge RC, Fein HG (1987) Release of multiple hormones by a direct action of interleukin-1 on pituitary cells. Science 238:519–521PubMedGoogle Scholar
  11. Besedovsky HO, Del Rey A, Sorkin E. Da Prada M, Keller HH (1979) Immunoregulation mediated by the sympathetic nervous system. Cell Immunol 48:346–352PubMedGoogle Scholar
  12. Blalock JE (1985) Proopiomelanocortin-derived peptides in the immune system. Clin Endocrinol (Oxf) 22:823–827Google Scholar
  13. Blalock JE (1988) Neuroendocrine peptide hormones in the immune system. Prog Neuroendocrinimmunol 1:9–12Google Scholar
  14. Bocchini G, Bonanno G, Caneveri A (1983) Influence of morphine and naloxone on human peripheral blood T-Iymphocytes. Drug Alcohol Depend 11:233–237PubMedGoogle Scholar
  15. Briggs JH, McKerron CG, Souhami RL, Taylor JE, Andrews H (1967) Severe systemic infections complicating “mainline” heroin addiction. Lancet 2:1227–1231PubMedGoogle Scholar
  16. Bryant HU, Roudebush RE (1991) Suppressive effects of morphine pellet implants on in vivo parameters of immune function. J Pharmacol Exp Ther 255:410–414Google Scholar
  17. Bryant HU, Bernton EW, Holaday JW (1987a) Immunosuppressive effects of chronic morphine treatment in mice. Life Sci 41:1731–1738PubMedGoogle Scholar
  18. Bryant HU, Shakarjian TK, Bernton EW, Holaday JW (1987b) Morphine induced immunosuppression in mice:effects of naloxone and morphine tolerance. Pharmacologist 29:106Google Scholar
  19. Bryant HU, Bernton EW, Holaday JW (1988a) Morphine pellet induced immunomodulation in mice:temporal relationships. J Pharmacol Exp Ther 245:913–920PubMedGoogle Scholar
  20. Bryant HU, Bernton EW, Kenner JR, Shakarjian TK, Holaday JW (1988b) Suppression of macrophage function and increased lethality to bacterial infection in mice given morphine pellet implants. FASEB J 2:A1260Google Scholar
  21. Bryant HU, Yoburn BC, Inturrisi CE, Bernton EW, Holaday JW (1988c) Morphine induced immunomodulation is not related to serum morphine concentrations. F;u J Pharmacol 149:165–169Google Scholar
  22. Bryant HU, Bernton EW, Holaday JW (1990) Immunomodulatory effects of chronic morphine treatment:pharmacologic and mechanistic studies. NIDA Res Monogr 96:131–149PubMedGoogle Scholar
  23. Bussiere JL, Taub DD, Eisenstein TK, Rogers TJ, Geller EB, Adler MW (1990) Differential effects of morphine on the antibody response. Pharmacologist 32:154Google Scholar
  24. Carr DJJ (1988) Opioid receptors on cells of the immune system. Prog Neuroendocrinimmunol 1:8–14Google Scholar
  25. Carr DJJ, DeCosta B, Jacobson AE, Bost KL, Blalock JE (1987) Immunoaffinitypurified opiate receptor specifically binds the δ-class opiate ligand, cis-(+)-3-methylfentanylisothiocyanate, SUPERFIT. FEBS Lett 224:272–280PubMedGoogle Scholar
  26. Carr DJJ, Bubien JK, Woods WT, Blalock JE (1988) Opioid receptors on murine splenocytes:possible coupling to K+ channels. Ann NY Acad Sci 540:694–697PubMedGoogle Scholar
  27. Carr DJJ, DeCosta BR, Kim CH, Jacobson AE, Guarcello V, Rice KC, Blalock JE (1989) Opioid receptors on cells of the immune system:evidence for delta-and kappa-classes. J Endocrinol 122:161–168PubMedGoogle Scholar
  28. Casale TB, Bowman S, Kaliner M (1984) Induction of human cutaneous mast cell degranulation by opiates and endogenous opioid peptides:evidence for opiate and non-opiate receptor participation. J Allergy Clin Immunol 73:775–78l.PubMedGoogle Scholar
  29. Chao CC, Sharp BM, Pomeroy C, Filice GA, Peterson PK (1990) Lethality of morphine in mice infected with Toxoplasma gondii. J Pharmacol Exp Ther 252:605–609PubMedGoogle Scholar
  30. Cherubin CE (1967) The medical sequelae of narcotic addiction. Ann Intern Med 67:23–33PubMedGoogle Scholar
  31. Donahoe RM, Madden JJ, Hollingsworth F, Shafer D, Falek A (1985) Morphine depression of T cell E-rosetting:definition of the process. Fed Proc 44:95–99PubMedGoogle Scholar
  32. Donahoe RM, Nicholson JKA, Madden JJ, Donahoe F, Shafer DA, Gordon D, Bokos P, Falek A (1986) Coordinate and independent effects of heroin, cocaine, and alcohol abuse on T-cell E-rosette formation and antigenic marker expression. Clin Immunol Immunopathol 41:254–264PubMedGoogle Scholar
  33. Donahoe RM, Bueso-Ramos C, Donahoe F, Madden JJ, Falek A (1987) Mechanistic implications of the findings that opiates and other drugs of abuse moderate T-cell surface receptors and antigenic markers. Ann NY Acad Sci 496:711–721PubMedGoogle Scholar
  34. Ebertz JM, Hermens JM, McMillan JC, Uno H, Hirshman C, Hanifin JM (1986) Functional differences between human cutaneous mast cells and basophils:a comparison of morphine-induced histamine release. Agents Actions 18:455–462PubMedGoogle Scholar
  35. Eisenstein TK, Meissler JJ, Geller EB, Adler MW (1990) Immunosuppression to tetanus toxoid induced by implanted morphine pellets. Ann NY Acad Sci 594:377–379Google Scholar
  36. Elliot GR, van Batenburg MJ, Dzoljic MR (1989) Morphine dependence modifies macrophage eicosanoid release. Agents Actions 23:32–33Google Scholar
  37. Ellis HV, Johnson AR, Moran NC (1970) Selective release of histamine from rat mast cells by several drugs. J Pharmacol Exp Ther 175:627–631PubMedGoogle Scholar
  38. Faith RE, Murgo AJ (1988) Inhibition of pulmonary metastases and enhancement of natural killer cell activity by methionine enkephalin. Brain Behav Immun 2:114–122PubMedGoogle Scholar
  39. Faith RE, Liang HJ, Murgo AJ, Plotnikoff NP (1984) Neuroimmunomodulation with enkephalins:enhancement of human natural killer cell activity in vitro. Clin Immunol Immunopathol 31:412–418PubMedGoogle Scholar
  40. Faith RE, Liang HJ, Plotnikoff NP, Murgo AJ, Nimeh NF (1987a) Neuroimmunomodulation with enkephalins:in vitro enhancement of natural killer cell activity in peripheral blood lymphocytes from cancer patients. Nat Immun Cell Growth Regul 6:88–98PubMedGoogle Scholar
  41. Faith RE, Murgo AJ, Clinkscales CW, Plotnikoff NP (1987b) Enhancement of host resistance to viral and tumor challenge by treatment with methionine enkephalin. Ann NY Acad Sci 496:137–145PubMedGoogle Scholar
  42. Farrar WL, Hill JM, Harel-Biellan A, Vinocour M (1987) The immune logical brain. Immunol Rev 100:361–378PubMedGoogle Scholar
  43. Felten DL, Felten SY, Carlson SL, Olschowka JO, Livnat S (1985) Noradrenergic and peptidergic innervation of lymphoid tissue. J Immunol 135:755s-765sPubMedGoogle Scholar
  44. Fiorica E, Spector S (1988) Opioid binding site in EL-4 thymoma cell line. Life Sci 42:199–206PubMedGoogle Scholar
  45. Fischer EG, Falke NE (1986) The influence of endogenous opioid peptides on venous granulocytes. In:Plotnikoff NP, Faith RE, Murgo AJ, Good RA (eds) Enkephalins and endorphins:stress and the immune system. Plenum, New York, pp 263–272Google Scholar
  46. Fischer EG, Falke NE (1987) Interaction of met-enkephalin with human granulocytes. Ann NY Acad Sci 496:146–150PubMedGoogle Scholar
  47. Foris G, Medgyesi GA, Gyimesi E, Hauck M (1984) Met-enkephalin induced alterations of macrophage functions. Mol Immunol 21:747–750PubMedGoogle Scholar
  48. Foris G, Medgyesi GA, Hauck M (1986) Bidirectional effect of met-enkephalin on macrophage effector functions. Mol Cell Biochem 69:127–137PubMedGoogle Scholar
  49. Foster JS, Moore RN (1987) Dynorphin and related opioid peptides enhance tumoricidal activity mediated by murine peritoneal macrophages. J Leuk Bioi 42:171–174Google Scholar
  50. Gilman SC, Schwartz JM, Milner JM, Bloom FE, Feldman JD (1982) β-Endrophin enhances lymphocyte proliferative responses. Proc Natl Acad Sci USA 79:4226–4230PubMedGoogle Scholar
  51. Ginzburg HM, Weiss SH, MacDonald MG, Hubbard RL (1985) HTLV-III exposure among drug abusers. Cancer Res 45 Suppl:4605SPubMedGoogle Scholar
  52. Grosman N (1981) Histamine release from isolated rat mast cells:effects of morphine and related drugs and their interaction with compound 48/80. Agents Actions 11:196–203PubMedGoogle Scholar
  53. Gungor M, Genc E, Sagduyu, Eroglu L, Hoyuncuoglu H (1980) Effect of chronic administration of morphine on primary immune response in mice. Experientia 36:1309–1310PubMedGoogle Scholar
  54. Gyires K, Budavari I, Furst S, Molnar I (1985) Morphine inhibits the carrageenaninduced oedema and the chemoluminescence of leukocytes stimulated by zymosan. J Pharm Pharmacol 37:100–104PubMedGoogle Scholar
  55. Hazum E, Chang K-J, Cuatrecasas P (1979) Specific non opiate receptors for β-endrophin. Science 205:1033–1035PubMedGoogle Scholar
  56. Heijnen CJ, Bevers C, Kavelaars A, Ballieux RE (1986) Effect of alpha-endorphin on the antigen induced primary antibody response of human blood B cells in vitro. J Immunol 136:213–216PubMedGoogle Scholar
  57. Heijnen CJ, Croiset G, Zijlstra J, Ballieux RE (1987) Modulation of lymphocyte function by endorphins. Ann NY Acad Sci 496:161–165PubMedGoogle Scholar
  58. Hemmick LM, Bidlack JM (1987) β-Endrophin modulation of mitogen-stimulated calcium uptake by rat thymocytes. Life Sci 41:1971–1978PubMedGoogle Scholar
  59. Hermans JM, Ebertz JM, Hanifin JM, Hirshman CA (1985) Comparison of histamine release in human skin mast cells induced by morphine, fentanyl and oxymorphine. Anesthesiology 62:124–129Google Scholar
  60. Hewer T, Rose E, Ghadirian P, Castegnaro M, Bartsch H, Malaveille C, Day N (1978) Ingested mutagens from opium and tobacco pyrolysis products and cancer of the oesophagus. Lancet 2:494–496PubMedGoogle Scholar
  61. Ho WKK, Leung A (1979) The effect of morphine addiction on concanavalin-A mediated blastogenesis. Pharmacol Res Commun 11:413–419PubMedGoogle Scholar
  62. Holaday JW (1985) Endogenous opioids and their receptors. Current concepts. Upjohn, Kalamazoo, pp 11–19Google Scholar
  63. Hucklebridge FH, Hudspith BN, Muhamed J, Lydyard PM, Brostoff J (1989) Methionine-enkephalin stimulates in vitro proliferation of human peripheral lymphocytes via δ-opioid receptors. Brain Behav Immun 3:183–189PubMedGoogle Scholar
  64. Hucklebridge FH, Hudspith BN, Lydyard PM, Brostoff J (1990) Stimulation of human peripheral lymphocytes by methionine enkephalin and δ-selective opioid analogs. Immunopharmacology 19:87–91PubMedGoogle Scholar
  65. Hung CY, Lefkowitz SS, Geber WF (1973) Interferon inhibition by narcotic analgesics. Proc Soc Exp Bioi Med 142:106–110Google Scholar
  66. Jankovic BD, Maric D (1987a) Enkephalins and autoimmunity:differential effect of methionine en kephalin on experimental allergic encephalomyelitis in Wistar and Lewis rats. J Neurosci Res 18:88–94PubMedGoogle Scholar
  67. Jankovic BD, Maric D (1987b) Enkephalins and immunity. I. In vivo suppression and potentiation of humoral immune response. Ann NY Acad Sci 496:115–125PubMedGoogle Scholar
  68. Jerrells TR, Marietta CA, Eckardt MJ (1987) Corticosteroids in immunosuppression associated with ethanol administration to rats. Fed Proc 46:1023Google Scholar
  69. Johnson HM, Smith EM, Torres BA, Blalock JE (1982) Regulation of the in vitro antibody response by neuroendocrine hormones. Immunology 79:4171–4174Google Scholar
  70. Kay N, Allen J, Morley JE (1984) Endorphins stimulate normal human peripheral blood lymphocyte natural killer activity. Life Sci 35:53–59PubMedGoogle Scholar
  71. Kay N, Morley JE, van Ree JM (1987) Enhancement of human lymphocyte natural killing function by non-opioid fragments of β-Endrophin. Life Sci 40:1083–1087PubMedGoogle Scholar
  72. Krco CJ, Gores A, Go VLW (1986) Gastrointestinal regulatory peptides modulate in vitro immune reactions of mouse lymphoid cells. Clin Immunol Immunopathol 39:308–318PubMedGoogle Scholar
  73. Kusnecow AW, Husband AJ, King MC, Pang G, Smith R (1987) In vivo effects of β-Endrophin on lymphocyte proliferation and interleukin-2 production. Brain Behav Immun 1:88–97Google Scholar
  74. Lee NM (1990) Opioids and immunity. American Society of Pharmacology and Experimental Therapeutics Annual Meeting, Milwaukee, WI, USAGoogle Scholar
  75. Lefkowitz SS, Chiang CY (1975) Effects of certain abused drugs on hemolysin forming cells. Life Sci 17:1763–1769PubMedGoogle Scholar
  76. Levy EM, McIntosh T, Black PH (1986) Elevation of circulating beta-endorphin levels with concomitant depression of immune parameters after traumatic injury. J Trauma 26:246–249PubMedGoogle Scholar
  77. Lewis JW, Shavit Y, Terman GW, Gale RP, Liebeskind JC (1983a) Stress and morphine affect survival of rats challenged with a mammary ascites tumor (MAT 13762B). Nat Immun Cell Growth Regul 3:43–50PubMedGoogle Scholar
  78. Lewis JW, Shavit Y, Terman GW, Nelson LR, Gale RP, Liebeskind JC (1983b) Apparent involvement of opioid peptides in stress-induced enhancement of tumor growth. Peptides 4:635–638PubMedGoogle Scholar
  79. Liu JS, Garrett KM, Lin SC, Way EL (1983) The effects of opiates on calcium accumulation on rat peritoneal mast cells. Eur J Pharmacol 91:335–341PubMedGoogle Scholar
  80. Lopker A, Abood LG, Hoss W, Lionetti FJ (1980) Stereoselective muscarinic acetylcholine and opiate receptors in human phagocytic leukocytes. Bicochem Pharmacol 29:1361–1365Google Scholar
  81. Louria DB, Hensle T, Rose J (1967) The major medical complications of heroin addiction. Ann Intern Med 67:1–22PubMedGoogle Scholar
  82. Lowman MA, Rees PH, Benyon RC, Church MK (1988) Human mast cell heterogeneity:histamine release from mast cells dispersed from skin, kung, adenoids, tonsils, and colon in response to IgE-dependent and nonimmunologic stimuli. J Allergy Clin Immunol 81:590–597PubMedGoogle Scholar
  83. Luza J (1989) Effect of morphine on leukocyte kinetics. II. Effect of morphine on the white blood cell count of rabbits peripheral blood following atropine induced blockade of the parasympathicus and epinephrectomized animals. Acta Univ Palacki Olomuc Fac Med 123:113–121PubMedGoogle Scholar
  84. Madden JJ, Donahoe RM, Zwemer-Collins J, Shafer DA, Falek A (1987) Binding of naloxone to human T-Iymphocytes. Biochem Pharmacol 36:4103–4109PubMedGoogle Scholar
  85. Mandler RN, Biddison WE, Mandler R, Serrate SA (1986) Beta-endorphin augments the cytolytic activity and interferon production of natural killer cells. J Immunol 136:934–939PubMedGoogle Scholar
  86. Maric D, Jankovic BD (1987) Enkephalins and immunity. II. In vivo modulation of cell mediated immunity. Ann NY Acad Sci 496:126–136PubMedGoogle Scholar
  87. Marks MJ, Medzihradsky F (1974) Transport and interaction of drugs in leukocytes. Biochem Pharmacol 23:2951–2962PubMedGoogle Scholar
  88. Mathews PM, Froelich CJ, Sibbit WL, Bankhurst AD (1983) Enhancement of natural cytotoxicity by β-Endrophin. J Immunol 130:1658–1662PubMedGoogle Scholar
  89. McCain HW, Lamster IB, Bozzone JM, Grbic JT (1982) β-Endrophin modulates human immune activity via non-opiate receptor mechanisms. Life Sci 31:1619–1624PubMedGoogle Scholar
  90. McCain HW, Bilotta J, Lamster IB (1987) Endorphinergic modulation of immune function:potent action of the dipeptide glycyl-L-glutamine. Life Sci 41:169–176PubMedGoogle Scholar
  91. McDonough RJ, Madden JJ, Falek A, Shafer DA, Pline M, Gordon D, Bokos P, Kuehnle JC, Mendelson J (1980) Alteration of T and null lymphocyte frequencies in the peripheral blood of human opiate addicts:in vivo evidence for opiate receptor sites on T lymphocytes. J Immunol 125:2539–2543PubMedGoogle Scholar
  92. Mehrishi IN, Mills IH (1983) Opiate receptors on lymphocytes and platelets in man. Clin Immunol ImmunopathoI 27:240–249Google Scholar
  93. Meismiri KD, Isom GE (1978) Influence of immune stimulation and suppression on morphine physical dependence and tolerance. Res Commun Chern Pathol Pharmacol 19:85–99Google Scholar
  94. Mendelsohn LG, Kerchner GA, Culwell M, Ades EW (1985) Immunoregulation by opioid peptides:absence of classical opioid receptors on human mononuclear cells. J Clin Lab Immunol 16:125–132PubMedGoogle Scholar
  95. Miller DJ, Kleber H, Bloomer JR (1979) Chronic hepatitis associated with drug abuse:significance of hepatitis B virus. Yale J Bioi Med 52:135–140Google Scholar
  96. Miller GC, Murgo AJ, Plotnikoff NP (1983) Enkephalin-enhancement of active T-cell rosettes from lymphoma patients. Clin Immunol Imniunopathol 26:446–451Google Scholar
  97. Miller GC, Murgo AJ, Plotnikoff NP (1984) Enkephalin-enhancement of active T-cell rosettes from normal volunteers. Clin Immunol Immunopathol 31:132–137PubMedGoogle Scholar
  98. Muldoon SM, Donlon MA, Todd R, Helgeson EA, Freas W (1984) Plasma histamine and hemodynamic responses following administration of nalbuphine and morphine. Agents Actions 15:229–234PubMedGoogle Scholar
  99. Nagy JT, Foris G, Paragh G, Plotnikoff NP (1987) Possible correction of defective polymorphonuclear cell functions in type-2 diabetes mellitus by met-enkephalin. Ann NY Acad Sci 496:166–169PubMedGoogle Scholar
  100. Nagy JT, Foris G, Fulop T, Paragh G, Plotnikoff NP (1988) Activation of the lipoxygenase pathway in the methionine enkephalin induced respiratory burst in human polymorphonuclear leukocytes. Life Sci 42:2299–2306PubMedGoogle Scholar
  101. Nahas G, Leger C, Desoize B, Banchereau J (1981) Inhibitory effects of psychotropic drugs on blastogenesis of cultured lymphocytes. In:Sharma RP (ed) Immunologic considerations in toxicology. CRC, Boca Rorton, pp 83–91Google Scholar
  102. Norland K, Mutt V (1986) Influence of beta-endorphin, somatostatin, substance P and vasoactive intestinal peptide on the proliferative response of human peripheral blood T lymphocytes to mercuric chloride. Int Arch Allergy Appl Immunol 80:326–328Google Scholar
  103. Norman DC, Yamamura RH, Chang MP (1988) Differential enhancing effect of β-Endrophin on mitogenic Iymphoproliferation in young and aged mice. FASEB J 2:A529Google Scholar
  104. Novick DM, Ochshorn M, Ghali V, Croxson TS, Mercer WD, Chiorazzi N, Kreek MJ (1989) Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients. J Pharmacol Exp Ther 250:606–610PubMedGoogle Scholar
  105. Oleson DR, Johnson DR (1988) Regulation of human natural cytotoxicity by enkephalins and selective opiate agonists. Brain Behav Immun 2:171–186PubMedGoogle Scholar
  106. Ovadia H, Nitsan P, Abramsky O (1989) Characterization of opiate binding sites on membranes of rat lymphocytes. J Neuroimmunol 21:93–102PubMedGoogle Scholar
  107. Parillo JE, Fauci AS (1979) Mechanisms of glucocorticoid action on immune processes. Annu Rev Pharmacol Toxicol 19:129–201Google Scholar
  108. Pellis NR, Harper C, Dafny N (1986) Suppression of the induction of delayed type hypersensitivity in rats by repetitive morphine treatments. Exp Neurol 93:92–97PubMedGoogle Scholar
  109. Pellis NR, Kletzly NE, Dougherty PM, Aronowski J, Dafny N (1987) Participation of lymphoid cells in the withdrawal syndrome of opiate dependent rats. Life Sci 40:1589–1593PubMedGoogle Scholar
  110. Perrit D, Jerrells TR, Holaday JW, Bryant HU (1988) Suppression of interleukin-2 production with chronic morphine treatment. FASEB J 2:A485Google Scholar
  111. Peterson PK, Sharp B, Gekker G, Brummit C, Keane WF (1987) Opioid mediated suppression of interferon-γ production by cultured peripheral blood mononuclear cells. J Clin Invest 80:824–831PubMedGoogle Scholar
  112. Petty HR, Berg KA (1988) Combinative ligand-receptor interactions:epinephrine depresses RA W264 macrophage antibody-dependent phagocytosis in the absence and presence of met-enkephalin. J Cell Physiol 134:281–286PubMedGoogle Scholar
  113. Petty HR, Martin SM (1989) Combinative ligand-receptor interactions:effects of cAMP, epinephrine, and met-enkephalin on RA W264 macrophage morphology, spreading, adherence and microfilaments. J Cell Physiol 138:247–256PubMedGoogle Scholar
  114. Plotnikoff NP, Miller GC (1983) Enkephalins as immunomodulators. Int J Immunopharmacol 5:437–441PubMedGoogle Scholar
  115. Plotnikoff NP, Kastin AP, Coy DH, Christensen CW, Schally SV, Spirites MA (1976) Neuropharmacological actions of enkephalin after systemic administration. Life Sci 19:1283–1288PubMedGoogle Scholar
  116. Plotnikoff NP, Murgo AJ, Miller GC, Corder CN, Faith RE (1985) Enkephalins:immunomodulators. Fed Proc 44:118–122PubMedGoogle Scholar
  117. Plotnikoff NP, Wybran J, Nimeh NF, Miller GC (1986) Methionine enkephalin:enhancement of T-cells in patients with Kaposi’s sarcoma (AIDS). Psychopharmacol Bull 22:695–697Google Scholar
  118. Prete R, Levin ER, Pedram A (1986) The in vitro effects of endogenous opioids on natural killer cells, antigen-specific cytolytic T-cells and T-cell subsets. Exp Neurol 92:349–359PubMedGoogle Scholar
  119. Prieto J, Subira ML, Castilla A, Arroyo JL, Serrano M (1989a) Opioid peptides modulate the organization of vimentin filaments, phagocytic activity and expression of surface molecules in monocytes. Scand J ImmunoI 29:391–398Google Scholar
  120. Prieto J, Subira ML, Castilla A, Serano M (1989b) Naloxone-reversible monocyte dysfunction in patients with chronic fatigue syndrome. Scand J Immunol 30:13–20PubMedGoogle Scholar
  121. Robert-Guroff M, Weiss SH, Giron JA, Jennings AM, Ginzburg HM, Margolis IB, Blattner WA, Gallo RC (1986) Prevalence of antibodies to HTLV-I, -II and-III in intravenous drug abusers from an AIDS endemic region. JAMA 255:3133–3145PubMedGoogle Scholar
  122. Rogers TJ, Taub DD, Eisenstein TK, Geller K, Adler M (1992) Immunomodulatory activity of kappa-, mu-, and delta selective opioid compounds. NIDA Res Monogr (in press)Google Scholar
  123. Rossier J, French WD, Rivier C, Ling N, Guillemin R, Bloom FE (1977) Footshock induced stress increases β-endrophin levels in blood but not brain. Nature 270:618–620PubMedGoogle Scholar
  124. Rowland RRR, Chukwuocha R, Tokuda S (1987) Modulation of the in vitro murine immune response by met-enkephalin. Brain Behav Immun 1:342–348PubMedGoogle Scholar
  125. Saland LC, Van Epps DE, Ortix E, Samora A (1983) Acute injections of opiate peptides into the rat cerebral ventricle:a macrophage like cellular response. Brain Res Bull 10:523–528PubMedGoogle Scholar
  126. Saphier D, Abramsky O, Mor G, Ovadia H (1987) Multiunit electrical activity in conscious rats during an immune response. Brain Behav Immun 1:40–51PubMedGoogle Scholar
  127. Savona S, Nardi MA, Lennette ET, Karpatkin S (1985) Thrombocytopenic purpura in narcotic addicts. Ann Intern Med 102:737–741PubMedGoogle Scholar
  128. Schuster CR (1988) Keynote address:NIDA technical review on current chemical and pharmacological advances on drugs of abuse which alter immune function and their impact upon HIV infection. Rockville, MD, USAGoogle Scholar
  129. Schweigerer L, Schmidt W, Teschemacher H, Gramsch C (1985) β-Endrophin:surface binding and internalization in thymoma cells. Proc Natl Acad Sci (USA) 82:5751–5755Google Scholar
  130. Seeger TF, Sforzo GA, Pert CB, Pert A (1984) In vivo autoradiography:visualization of stress-induced changes in opiate receptor occupancy in the rat brain. Brain Res 305:303–311PubMedGoogle Scholar
  131. Sharp BM, Keane WF, Suh HJ, Gekker G, Tsukayama D, Peterson PK (1985) Opioid peptides rapidly stimulate superoxide production by human polymorphonuclear leukocytes and macrophages. Endocrinology 117:793–795PubMedGoogle Scholar
  132. Shavit Y, Lewis JW, Terman GW, Gale RP, Liebeskind JC (1984) Opioid peptides mediate the suppressive effect of stress on natural killer cell cytotoxicity. Science 223:188–190PubMedGoogle Scholar
  133. Shavit Y, Depaulis A, Martin FC, Terman GW, Pechnick RN, Zane CJ, Gale RP, Liebeskind JC (1986a) Involvement of brain opiate receptors in the immunesuppressive effect of morphine. Proc Nat! Acad Sci (USA) 83:7114–7117Google Scholar
  134. Shavit Y, Terman GW, Lewis JW, Zane CJ, Gale RP, Liebeskind JC (1986b) Effects of footshock stress and morphine on natural killer lymphocytes in rats:studies of tolerance and cross-tolerance. Brain Res 372:382–385PubMedGoogle Scholar
  135. Simon RH, Arbo TE, Lundy J (1984) Beta-endorphin injected into the nucleus of the raphe magnus facilitates metastatic tumor growth. Brain Res Bull 12:487–491PubMedGoogle Scholar
  136. Simpkins C, Dickey C, Fink M (1984) Human neutrophil migration is enhanced by beta-endorphin. Fed Proc 43:913Google Scholar
  137. Singh VK, Jakabovic A, Thomas DA (1980) Suppressive effects of methadone on human blood lymphocytes. Immunol Lett 2:177–182Google Scholar
  138. Srisuchart B, Fuchs BA, Sikorski EE, Munson AE, Loveless SE (1989) Anti-tumor activity of en kephalin analogs in inhibiting PYB6 tumor growth in mice and immunological effects of methionine enkephalinamide. Int J Immunopharmacol 11:487–500PubMedGoogle Scholar
  139. Tharp MD, Kagey-Sobotka A, Fox CC, Marone G, Lichtenstein LM, Sullivan TJ (1987) Functional heterogeneity of human mast cells from different anatomic sites:in vitro responses to morphine sulfate. J Allergy Clin Immunol 79:646–653PubMedGoogle Scholar
  140. Tubaro E, Borelli G, Croce C, Cavallo G, Santiangeli C (1983) Effect of morphine on resistance to infection. J Infect Dis 148:656–666PubMedGoogle Scholar
  141. Tubaro E, Avico U, Santiangeli C, Zuccaro P, Cavallo G, Pacifici R, Croce C, Borelli G (1985) Morphine and methadone impact on human phagocytic physiology. Int J Immunopharmacol 7:865–874PubMedGoogle Scholar
  142. Tubaro E, Santiangeli C, Belogi L, Borelli G, Cavallo G, Croce C (1987) Methadone vs morphine:comparisons of their effect on phagocytic functions. Int J Immunopharmacol 9:79–88PubMedGoogle Scholar
  143. Van Epps DE, Saland L (1984) β-Endrophin and met-enkephalin stimulate human peripheral blood mononuclear cell chemotaxis. J Immunol 132:3046–3053PubMedGoogle Scholar
  144. Watson RR, Prabhala RH, Darban HR, Yahya MD, Smith TL (1988) Changes in lymphocyte and macrophage subsets due to morphine and ethanol treatment during a retrovirus infection causing murine AIDS. Life Sci 43:v-xiPubMedGoogle Scholar
  145. Weber RJ, Pert A (1989) The periaqueductal gray matter mediates opiate-induced immunosuppression. Science 245:188–190PubMedGoogle Scholar
  146. Weber RJ, Ikejiri B, Rice KC, Pert A, Hagan AA (1987) Opiate receptor mediated regulation of the immune response in vivo. NIDA Res Monogr 76:341–348PubMedGoogle Scholar
  147. Wesley HJ, Kleiss KJ, Kelley KW, Wong PKY, Yuen PH (1986) Newcastle disease virus-infected splenocytes express the proopiomelanocortin gene. J Exp Med 163:1589–1594Google Scholar
  148. Williamson SA, Knight RA, Lightman SL, Hobbs JR (1988) Effects of beta endorphin on specific immune responses in man. Immunology 65:47–51PubMedGoogle Scholar
  149. Wolfe SA, Kulsakdinun C, Battaglia G, Jaffe JH, De Souza EB (1988) Initial identification and characterization of sigma receptors on human peripheral blood leukocytes. J Pharmacol Exp Ther 247:1114–1119PubMedGoogle Scholar
  150. Wybran J, Appelboom T, Famaey J-P, Govaerts A (1979) Suggestive evidence for receptors for morphine and methionine-enkephalin on normal human blood T lymphocytes. J Immunol 123:1068–1070PubMedGoogle Scholar
  151. Wybran J, Schandene L, van Vooren JP, Vandermoten G, Latinne D, Sonnet J, De Bruyere M, Taelman H, Plotnikoff NP (1987) Immunologic properties of methionine enkephalin, and therapeutic implications in AIDS, ARC and cancer. Ann NY Acad Sci 496:108–114PubMedGoogle Scholar
  152. Yamasaki Y, Shimamura O, Kizu A, Nakagawa M, Ijichi H (1982) IgE-mediated 14C-serotonin release from rat mast cells modulated by morphine and endorphins. Life Sci 31:471–478PubMedGoogle Scholar
  153. Yamasaki Y, Shimamura O, Kizu A, Nakagawa M, Ijichi H (1983) Interactions of morphine with PGE1 isoproterenol, dopamine and aminophylline in rat mast cells; their effect on IgE-mediated 14C-serotonin release. Agents Actions 13:21–28PubMedGoogle Scholar
  154. Zagon IS, McLaughlin PJ (1981) Naloxone prolongs the survival time of mice treated with neuroblastoma. Life Sci 28:1095–1102PubMedGoogle Scholar
  155. Zunich KM, Kirkpatrick CH (1988) Methionine enkephalin as immunomodulator therapy in human immunodeficiency virus infections:clinical and immunological effects. J Clin Invest 8:95–102Google Scholar
  156. Zurawski G, Benedik M, Kamb BJ, Abrams JS, Zurawski SM, Lee FD (1986) Activation of mouse T-helper cells induces abundant preproenkephalin mRNA synthesis. Science 232:772–775PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1993

Authors and Affiliations

  • H. U. Bryant
  • J. W. Holaday

There are no affiliations available

Personalised recommendations